These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 7529237)
21. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Bae SK; Bae MH; Ahn MY; Son MJ; Lee YM; Bae MK; Lee OH; Park BC; Kim KW Cancer Res; 1999 Dec; 59(23):5989-94. PubMed ID: 10606246 [TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318 [TBL] [Abstract][Full Text] [Related]
23. Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas. Dragović T; Deddish PA; Tan F; Weber G; Erdös EG Lab Invest; 1994 Jan; 70(1):107-13. PubMed ID: 8302012 [TBL] [Abstract][Full Text] [Related]
25. Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development. Qiu LW; Yao DF; Zong L; Lu YY; Huang H; Wu W; Wu XH Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):406-11. PubMed ID: 18693177 [TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Kim KW; Bae SK; Lee OH; Bae MH; Lee MJ; Park BC Cancer Res; 1998 Jan; 58(2):348-51. PubMed ID: 9443416 [TBL] [Abstract][Full Text] [Related]
27. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines. Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140 [TBL] [Abstract][Full Text] [Related]
28. Phenotypic diversity of gamma-glutamyltranspeptidase activity and protein secretion in hepatoma cell lines. Richards WL; Tsukada Y; Potter VR Cancer Res; 1982 Apr; 42(4):1374-83. PubMed ID: 6120761 [TBL] [Abstract][Full Text] [Related]
29. Characterization of the IGF axis components in isolated rat hepatic stellate cells. Scharf JG; Knittel T; Dombrowski F; Müller L; Saile B; Braulke T; Hartmann H; Ramadori G Hepatology; 1998 May; 27(5):1275-84. PubMed ID: 9581681 [TBL] [Abstract][Full Text] [Related]
30. Transcripts of the insulin-like growth factors I and II in human hepatoma. Su TS; Liu WY; Han SH; Jansen M; Yang-Fen TL; P'eng FK; Chou CK Cancer Res; 1989 Apr; 49(7):1773-7. PubMed ID: 2466561 [TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor II/mannose 6-phosphate-receptor expression in liver and serum during acute CCl4 intoxication in the rat. De Bleser PJ; Scott CD; Niki T; Xu G; Wisse E; Geerts A Hepatology; 1996 Jun; 23(6):1530-7. PubMed ID: 8675174 [TBL] [Abstract][Full Text] [Related]
32. Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II. Lund P; Schubert D; Niketeghad F; Schirmacher P Cancer Lett; 2004 Mar; 206(1):85-96. PubMed ID: 15019164 [TBL] [Abstract][Full Text] [Related]
33. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression. Breuhahn K; Vreden S; Haddad R; Beckebaum S; Stippel D; Flemming P; Nussbaum T; Caselmann WH; Haab BB; Schirmacher P Cancer Res; 2004 Sep; 64(17):6058-64. PubMed ID: 15342387 [TBL] [Abstract][Full Text] [Related]
34. Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells. Zarrilli R; Pignata S; Romano M; Gravina A; Casola S; Bruni CB; Acquaviva AM Cell Growth Differ; 1994 Oct; 5(10):1085-91. PubMed ID: 7848910 [TBL] [Abstract][Full Text] [Related]
35. Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat. Pascale RM; De Miglio MR; Muroni MR; Simile MM; Daino L; Seddaiu MA; Pusceddu S; Gaspa L; Calvisi D; Manenti G; Feo F Hepatology; 1998 Feb; 27(2):452-61. PubMed ID: 9462644 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells. Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II. Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022 [TBL] [Abstract][Full Text] [Related]
38. In situ hybridization studies on expression of albumin and alpha-fetoprotein during the early stage of neoplastic transformation in rat liver. Evarts RP; Nagy P; Marsden E; Thorgeirsson SS Cancer Res; 1987 Oct; 47(20):5469-75. PubMed ID: 2443240 [TBL] [Abstract][Full Text] [Related]
39. Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product. Kim SO; Park JG; Lee YI Cancer Res; 1996 Aug; 56(16):3831-6. PubMed ID: 8706031 [TBL] [Abstract][Full Text] [Related]
40. [Significance and expression of insulin-like growth factor II and its receptor in hepatocellular carcinogenesis]. Fan Z; Yang D; Qin H Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):84-6. PubMed ID: 10861110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]